Read More...

Hepatitis C

HEPATITIS C (HCV)

INTRODUCTION

Hepatitis C is a viral infection of the liver caused by the hepatitis C virus (HCV). It can present as both acute (short-term) and chronic (long-term) disease. The severity varies from a mild, short illness to a serious lifelong condition.

A large proportion of infected individuals may eventually develop advanced liver disease, making early diagnosis and timely treatment essential.

HCV is primarily a blood-borne infection, commonly transmitted through:

  • Unsafe injection practices
  • Improper sterilization of medical equipment
  • Transfusion of unscreened blood or blood products

Currently, no vaccine is available for hepatitis C, although ongoing research is in progress.

EPIDEMIOLOGY

  • Approximately 130–150 million people worldwide are living with chronic HCV infection.
  • Many of these individuals may progress to cirrhosis or liver cancer.
  • Around 500,000 deaths annually are attributed to HCV-related liver disease.
  • Antiviral treatment can cure nearly 90% of cases, but access to diagnosis and therapy remains limited.
  • About 15–45% of infected individuals clear the virus spontaneously within 6 months.
  • The remaining 55–85% develop chronic infection, with 15–30% progressing to cirrhosis over 20 years.

TYPES OF HEPATITIS C

  • 1. Acute Hepatitis C
    • Occurs within the first 6 months after exposure
    • Often asymptomatic
    • In most cases, progresses to chronic infection
  • 2. Chronic Hepatitis C
    • Long-term infection where the virus remains in the body
    • Can persist for life if untreated
    • May lead to cirrhosis, liver failure, or hepatocellular carcinoma

MODE OF TRANSMISSION

Hepatitis C spreads when infected blood enters the body of a healthy person. Common routes include:

  • Sharing needles or drug injection equipment
  • Blood transfusions or organ transplants (especially before proper screening practices)
  • High-risk sexual practices (especially in HIV-positive individuals or multiple partners)
  • Use of non-sterile instruments for tattoos or piercings

It is important to note that HCV is not transmitted through:

  • Hugging, kissing, or handshakes
  • Sharing food or utensils
  • Coughing or sneezing
  • Mosquito bites or animal contact

HIGH-RISK GROUPS

Individuals who should be screened include:

  • Current or past intravenous drug users
  • Patients on long-term hemodialysis
  • Individuals with abnormal liver enzyme levels (ALT)
  • Persons with HIV infection
  • Recipients of blood transfusions or organ transplants before 1992
  • Healthcare workers exposed to needle-stick injuries
  • Children born to HCV-infected mothers
  • Individuals who received clotting factors before 1987

CLINICAL MANIFESTATIONS

  • Many patients remain asymptomatic, especially in early stages
  • Symptoms of acute infection may appear 2 weeks to 6 months after exposure
  • Chronic infection symptoms may take years to develop

Common symptoms include:

  • Fever
  • Fatigue
  • Loss of appetite
  • Nausea and vomiting
  • Abdominal pain
  • Dark urine
  • Pale stools
  • Joint pain
  • Jaundice

DIAGNOSIS

Screening Test

  • Anti-HCV antibody test (EIA) detects exposure to the virus

Confirmatory Test

  • HCV RNA PCR test confirms active infection

MANAGEMENT

Treatment Goals

  • Eliminate the virus from the body
  • Prevent progression to cirrhosis or liver cancer
  • Improve survival and quality of life

Antiviral therapy is highly effective and can cure most patients.

PREGNANCY AND HCV

  • Screening is recommended only in women with risk factors
  • About 6% of infants born to infected mothers may acquire infection
  • Transmission occurs mainly during childbirth
  • Breastfeeding is generally safe, except when nipples are cracked or bleeding
  • Infants should be tested after 18 months of age

PATIENT EDUCATION & PRECAUTIONS

  • Avoid sharing personal items like razors or toothbrushes
  • Cover open wounds to prevent blood exposure
  • Do not donate blood, organs, or semen
  • Avoid alcohol as it accelerates liver damage
  • Consult a doctor before taking medications or supplements
  • Participation in support groups may be beneficial

PREVENTION

  • Do not share needles or injection equipment
  • Ensure proper hand hygiene before injections
  • Avoid unlicensed tattooing or piercing services
  • Do not use items contaminated with infected blood
  • Note: Bleach is not effective in killing HCV
 

Copyright © Institute of Liver & Biliary Sciences 2026. All rights reserved. Application Development and Maintenance by Cyfuture